🇺🇸 FDA
Patent

US 8765731

Benzimidazole analogues for the treatment or prevention of flavivirus infections

granted A61PA61P1/16A61P3/00

Quick answer

US patent 8765731 (Benzimidazole analogues for the treatment or prevention of flavivirus infections) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/16, A61P3/00, A61P31/14